Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 345
Priorities for the National Vaccine Plan Appendix G Acronyms ACIP Advisory Committee on Immunization Practices AE adverse event AHIP America’s Health Insurance Plans AMC Advance Market Commitment ARRA American Recovery and Reinvestment Act ASPR Assistant Secretary for Preparedness and Response BARDA Biomedical Advanced Research and Development Authority BLA Biological License Application BRFSS Behavioral Risk Factor Surveillance System CAVD Collaboration for AIDS Vaccine Discovery CBER Center for Biologics Evaluation and Research CDC Centers for Disease Control and Prevention CISA Clinical Immunization Safety Assessment CMS Centers for Medicare & Medicaid Services DALY disability-adjusted life year DoD Department of Defense DTaP/DTP diphtheria, pertussis (whooping cough), and tetanus vaccine EHR electronic health record EMEA European Medicines Agency EMR electronic medical record
OCR for page 346
Priorities for the National Vaccine Plan FDA Food and Drug Administration FE(L)TP Field Epidemiology Training Program/Field Epidemiology and Laboratory Training Program FTE full-time equivalent/employee GAVI Global Alliance for Vaccines and Immunisation HEDIS Healthcare Effectiveness Data and Information Set HHS Department of Health and Human Services Hib Haemophilus influenzae type B HIT health information technology HPV human papilloma virus HRSA Health Resources and Services Administration IAVG Interagency Vaccine Group IAVI International AIDS Vaccine Initiative IFFIm International Financing Facility for Immunization IIS immunization information systems IOM Institute of Medicine IPV inactivated polio vaccine ISO Immunization Safety Office IT information technology MCO managed care organization MMR measles, mumps, and rubella vaccine MMRV measles, mumps, rubella, and chickenpox vaccine NCHS National Center for Health Statistics NCI National Cancer Institute NCQA National Committee for Quality Assurance NCVIA National Childhood Vaccine Injury Act NDA New Drug Application NHIN National Health Information Network NIAID National Institute of Allergy and Infectious Diseases NICHD National Institute of Child Health and Human Development NIH National Institutes of Health NIS National Immunization Survey NVAC National Vaccine Advisory Committee NVIC National Vaccine Information Center NVP National Vaccine Plan NVPO National Vaccine Program Office ONCHIT Office of the National Coordinator for Health Information Technology OPHS Office of Public Health and Science OPV oral polio vaccine PAHO Pan American Health Organization PATH Program for Appropriate Technology in Health
OCR for page 347
Priorities for the National Vaccine Plan PDP product development partnership PEPPPI Public Engagement Pilot Project on Pandemic Influenza PHS Public Health Service PRISM Post-Licensure Rapid Immunization Safety Monitoring RRV-TV Tetravalent Rhesus-based Rotavirus Vaccine RVP Rotavirus Vaccine Program SARS severe acute respiratory syndrome SCHIP State Children’s Health Insurance Program SIVR Strategic Issues in Vaccine Research TB tuberculosis UNICEF United Nations Children’s Fund USAID United States Agency for International Development VA Department of Veterans Affairs VAERS Vaccine Adverse Event Reporting System VFC Vaccines for Children VHC Vaccine Healthcare Center VICP Vaccine Injury Compensation Program VPACE Vaccine Policy Analysis Collaborative VPD vaccine-preventable disease VSD Vaccine Safety Datalink WHO World Health Organization
OCR for page 348
Priorities for the National Vaccine Plan This page intentionally left blank.